Medication reference
Methyldopate
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Methyldopate ( Aldomet ®) (opens in a new tab)Original source URL: https://globalrph.com/dilution/methyldopate-aldomet/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/methyldopate-aldomet/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:48:26.494092+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- 813e12aa64fb94351a487fb25ce44377d59f434d80da4acc0089dab72826b1a9
- Original response SHA-256
- 91362faf37712d824d13e315c928844764ffd43535263e08f6a0db39f7b32d28
- Source body SHA-256
- 2bbbcdd3db08d6b1c20316fb4dbe095e73f58af3af718fb87fd0939026730df7
Methyldopate ( Aldomet ®) |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| D5W |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| [0 to 500 mg] [100 ml] [60 min] [over 500 mg] [250 ml] [60 min] |
Stability / Miscellaneous |
| EXP: 1 DAY (RT)
DOSAGE AND ADMINISTRATION Add the desired dose of Methyldopate HCl Injection to 100 mL of Dextrose Injection 5%, USP. Alternatively the desired dose may be given in 5% dextrose in water in a concentration of 100 mg/10 mL. Give this intravenous infusion slowly over a period of 30 to 60 minutes. Adults: The usual adult dosage intravenously is 250 mg to 500 mg at six hour intervals as required. The maximum recommended intravenous dose is 1 gram every six hours. When control has been obtained, oral therapy with tablets may be substituted for intravenous therapy, starting with the same dosage schedule used for the parenteral route. The effectiveness and anticipated responses are described in the circular for tablets. Since methyldopate has a relatively short duration of action, withdrawal is followed by return of hypertension usually within 48 hours. This is not complicated by an overshoot of blood pressure. Occasionally tolerance may occur, usually between the second and third month of therapy. Adding a diuretic or increasing the dosage of methyldopa frequently will restore effective control of blood pressure. A thiazide may be added at any time during methyldopa therapy and is recommended if therapy has not been started with a thiazide or if effective control of blood pressure cannot be maintained on 2 grams of methyldopa daily. Methyldopa is largely excreted by the kidney and patients with impaired renal function may respond to smaller doses. Syncope in older patients may be related to an increased sensitivity and advanced arteriosclerotic vascular disease. This may be avoided by lower doses. HOW SUPPLIED Store at controlled room temperature 15°-30°C (59°-86°F) (See USP). Rx Only American Source: [package insert] |
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- current_label_review_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- methyldopate
Source ID
H51-730F468E90E964C21FBE80CD - Generic name
- Methyldopate
Source ID
H51-F1D88445CB888C7A6C966AA8 - Class
- Other intravenous medications
Source ID
H51-A11884D959C266D932EB856F - Subclass
- Legacy GlobalRPh directory entry
Source ID
H51-0537D4929FDDD20630146814 - Primary uses
- A specialized IV indication that requires confirmation in the current exact-product label and applicable specialty guidance.
Source ID
H51-5522CEDA1923435F2A322EA1
- A specialized IV indication that requires confirmation in the current exact-product label and applicable specialty guidance.
- Mechanism
- Is converted to alpha-methylnorepinephrine, a central alpha-2 agonist that reduces sympathetic outflow.
Source ID
H51-43759731FCA61E21C98898FF - Mechanism level
- drug_specific
Source ID
H51-9290CF203F8D5B00629AF64E - Basic dosing orientation
- The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy.
Source ID
H51-0F8475E8DF76904A137E6CF2 - Administration orientation
- Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required.
Source ID
H51-77A964941A048BA4883392FE - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-6873FC4EC122748ACCAA7164 - Key safety orientation
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-EC9BD8CFFF09053B082BC221
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
- Coverage path
- automatic_legacy_quick_reference
Source ID
H51-EB32D431FD22C7E7B7C5279B - Coverage path label
- Automatic legacy GlobalRPh quick reference
Source ID
H51-61949560B20F933B302DBD26 - Legacy title
- Methyldopate
Source ID
H51-20582276493F697FC43D2C4D - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-1859732C4F53737ADABD0530 - Search text
- Methyldopate Other intravenous medications Legacy GlobalRPh directory entry A specialized IV indication that requires confirmation in the current exact-product label and applicable specialty guidance. Is converted to alpha-methylnorepinephrine, a central alpha-2 agonist that reduces sympathetic outflow. The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy. Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required. Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Automatic legacy GlobalRPh quick reference
Source ID
H51-B7D4902223E585E16074C63B - Official access mode
- none
Source ID
H51-FB6AD8EEBBE830B361F27121 - Official access reason
- No source-backed DailyMed action has been verified for this umbrella or legacy record; identify the exact product before searching.
Source ID
H51-F91C1BED0249209EDE09E85A
No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- current_label_review_required
Source ID
H51-F4168BC3532B8E3E3EAFDD43 - Summary
- Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-C98A71D2389B909ECC077380 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-9B5AE7176954A860E71D34D9
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-51B5111EF91D8B4DC1CAD3B2
Historical Stability notes
Recovered v5.1 source content; historical, awaiting current review.
- Legacy product stability information is not automatically equivalent to a USP <797> BUD.
Source ID
H51-CD2972DA6BEAE6A3A6602D5F
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
methyldopateSource ID
H51-C61B35D25029C16B9898ED63Legacy title
MethyldopateSource ID
H51-92A113A9874FD12C09EFE148Generic name
MethyldopateSource ID
H51-2A8AC33D37EADC7BCD6F52ACClass
Other intravenous medicationsSource ID
H51-12C6D17398CE086A5DDEFD27Subclass
Legacy GlobalRPh directory entrySource ID
H51-A8FA6CF000F244E313FFB90BSummary
Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.Source ID
H51-6870557156B2D685D7E915CFPopulations
- Population not yet normalized
Source ID
H51-39DF96782DB56298BFA2A628
Evidence tier
Legacy catalog - migration review requiredSource ID
H51-1C9608BB18D885C150721916High alert
falseSource ID
H51-EEF1D9FB32E43142D450791CHazardous
falseSource ID
H51-47BB514AFC49CAC069BADB43Status
Legacy migrationSource ID
H51-0DCDCFFDD655624AC4EB7C8AVersion added
LegacySource ID
H51-24C501C09C128D4AB6E1D2ADSources
| Label | Url | Kind |
|---|---|---|
Source IDH51-DAEF482F8D4C6847B5F5862ESource IDH51-E3AAB0CE5C476E5F574DD87F | legacy:autoSource IDH51-EB504422FD2755A025446D42 | LegacySource IDH51-171D834AC14770043EB37AAB |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-B2F6DDFFCD22D4DA43176868 - Audited on
- 2026-08-30
Source ID
H51-C007B0AB097874510A8A7CC4 - Level
- red
Source ID
H51-F6C2D67E49BED6E4911E838A - Release gate
- unverified_or_unclassified_sources_do_not_release_as_current
Source ID
H51-4060468BAB1C018727A6390E - Exact current label candidate
- false
Source ID
H51-9EAA1C335F837660E02FB2DB - Reference url count
- 0
Source ID
H51-BB334A644473D6770ECD2FA4 - Broken reference count
- 0
Source ID
H51-DB95575473D5546945BAAD88 - Point of use confirmation required
- true
Source ID
H51-D328473C06879295E0C12250 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-8BB5484FCDCFB2E7495FC47B - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Methyldopate (opens in a new tab)
Source ID
H51-78E0AC608D1C7D0B7FB6B62B
Dosing source fields
Id
methyldopateSource ID
H51-543289438791B36F102ECBEAGeneric name
MethyldopateSource ID
H51-5A18A8C76967D5E40E075F71Coverage status
direct_official_label_access_plus_legacy_referenceSource ID
H51-34454677382FF9A75C304B67Package insert
- Query name
- Methyldopate
Source ID
H51-703DDA726FBE68B2346231C6 - Product and route must match
- true
Source ID
H51-EBE0EB8DD744AF5B5A63D461 - Live current label enabled
- false
Source ID
H51-03970CA24BCF41F5A708D066 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-DCA0A2B7EECAAB2FAC2A21CB - Direct official label access enabled
- true
Source ID
H51-3CA6F5085663BD5C9203AF4D - Outbound server request required
- false
Source ID
H51-DE479C093E695A2611DC06F4 - Local summary status
- not_bundled
Source ID
H51-1C03F5BFD67AB63514C0061A
Clinical review
- Locally normalized
- false
Source ID
H51-7290D477CF255535460B4347 - Reviewed
- 2026-08-29
Source ID
H51-D85F64926E5E7C2B9BDBE3D9 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-F8AF1C300ACAC19F022AB65C
Clinical release verification
- Audit version
- 3.4
Source ID
H51-ADF4F681A47FA10558369B71 - Audited on
- 2026-08-30
Source ID
H51-A8CF1397C282100F37DD3668 - Level
- red
Source ID
H51-8409C143A735FC3231DAD322 - Release gate
- unverified_or_unclassified_sources_do_not_release_as_current
Source ID
H51-73C8655EEBC92749F2BA25CD - Exact current label candidate
- false
Source ID
H51-3A15AA86C23195BD45F1E928 - Reference url count
- 0
Source ID
H51-D75502812A6C286DF2F12BC8 - Broken reference count
- 0
Source ID
H51-05A2E176391FCB175039ED97 - Point of use confirmation required
- true
Source ID
H51-0AE8E7373E09B024576961BF - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-EF6374528D69AF4C91A13405 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Methyldopate (opens in a new tab)
Source ID
H51-937A6EC4F8241AEE5072C42B
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- methyldopate
Source ID
H51-3D3F3D57EA9900A668EB1244 - Name
- Methyldopate
Source ID
H51-AAAB03FDFB296CC66447690E - Therapeutic class
- Other intravenous medications
Source ID
H51-DB6CC7C3B0468AD37296DF97 - Review version
- 3.1
Source ID
H51-B7ECFF0E7EAF5E77726FB400 - Review date
- 2026-08-30
Source ID
H51-59F6F25E9304E9614727A963 - Release status
- no_released_dilution_current_label_review_required
Source ID
H51-9B2F44A8D37345181B940FC0 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-DD106E013185F790A6C2D0A7 - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-6BA0DDC9912045C65963D8EF
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-A1A5B7E01A995A7D945FE279 - Reconstitution concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6611F6E69FF5EEB866816E7F - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-9FD2AD903232D089ACD76502 - Appropriate standardized containers
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-12D3DCEC8C8B88D4705C4F45 - Adult dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-FCE4DC838007CD8DC05DAED5 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-7AC122FA7C59B5E4155663D6 - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-08A619A5484766D799AB0020 - Infusion time
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-1CBB45269A2F7E228AB6168D - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-A00AE9D19A7178CEE0E382F2 - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-1F2C377A5D902D4F6651D9BF - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Methyldopate (opens in a new tab)
Source ID
H51-977187AD31BFCD468327A37D
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-9983A0534CA980610CE46A78
- Reconstitution concentration
- Primary
- not_found
Source ID
H51-296B733E8DF7540FF7F2E175
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-9386C8CCEF524C4CD4F1A047
- Appropriate standardized containers
- Primary
- not_found
Source ID
H51-317EF84A314F497B650D0A16
- Adult dosing range
- Primary
- not_found
Source ID
H51-BC7FDE570FAA4F13FAF7069C
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-95D08E09B3229D0C1C5FBB75
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-526AD33A1A990DB1418FEDB3
- Infusion time
- Primary
- not_found
Source ID
H51-37EF8E84ACB92A6B5AA362D9
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-712C6A39E0D56CE981DBA095
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-35501767652A2B7CE7F61327
- Population applicability
- Adult
- Applicability
- not_established
Source ID
H51-D373A3D3EB7CCFF7BB25252C - Guide generation allowed
- false
Source ID
H51-6893226C8E096EB48BC44D42
- Pediatric
- Applicability
- not_established
Source ID
H51-EF57071A832D483E11716B58 - Guide generation allowed
- false
Source ID
H51-3AC695377E9F04E088426CC4
- Neonatal
- Applicability
- not_established
Source ID
H51-BE46CED045EF5ADE4C6F98B2 - Guide generation allowed
- false
Source ID
H51-DB99074F7314DDCA208C4251
- Route presence
- Structured dilution
- false
Source ID
H51-EF91EBD5061CF02CF3230752 - Iv push
- false
Source ID
H51-90C2997E64718AE4DB8E0B15 - Continuous infusion
- false
Source ID
H51-DD331FAFE003374CFC5EBF93 - Pediatric source
- false
Source ID
H51-4C00E1F6989F165690F44800 - Neonatal source
- false
Source ID
H51-36F8F0C489D6E7201F856EDC
- Legacy reference
- Status
- not_available
Source ID
H51-98059E41404ADFF8F65A549D
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-8CA9FBE9EC35E59F12336D8D
- Source files
- catalog.json
Source ID
H51-F32F27884D1F7FD44668CE81 - dosing.json
Source ID
H51-890B22A1D71355AEB519EA65 - legacy-map.json
Source ID
H51-93E483296E03D93AF04ED495 - review-queue.json
Source ID
H51-A5A309E82665D119A2054A00
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-95E34F78E16C2930CF334886
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-C61B35D25029C16B9898ED63 | catalog.json/records/160/id | Historical; current review incomplete |
H51-92A113A9874FD12C09EFE148 | catalog.json/records/160/legacy_title | Historical; current review incomplete |
H51-2A8AC33D37EADC7BCD6F52AC | catalog.json/records/160/generic_name | Historical; current review incomplete |
H51-12C6D17398CE086A5DDEFD27 | catalog.json/records/160/class | Historical; current review incomplete |
H51-A8FA6CF000F244E313FFB90B | catalog.json/records/160/subclass | Historical; current review incomplete |
H51-6870557156B2D685D7E915CF | catalog.json/records/160/summary | Historical; current review incomplete |
H51-51B5111EF91D8B4DC1CAD3B2 | catalog.json/records/160/warnings/0 | Historical; current review incomplete |
H51-CD2972DA6BEAE6A3A6602D5F | catalog.json/records/160/stability_notes/0 | Historical; current review incomplete |
H51-39DF96782DB56298BFA2A628 | catalog.json/records/160/populations/0 | Historical; current review incomplete |
H51-1C9608BB18D885C150721916 | catalog.json/records/160/evidence_tier | Historical; current review incomplete |
H51-EEF1D9FB32E43142D450791C | catalog.json/records/160/high_alert | Historical; current review incomplete |
H51-47BB514AFC49CAC069BADB43 | catalog.json/records/160/hazardous | Historical; current review incomplete |
H51-0DCDCFFDD655624AC4EB7C8A | catalog.json/records/160/status | Historical; current review incomplete |
H51-F4543FE61B9F210BA9BC99BB | catalog.json/records/160/reviewed | Historical; current review incomplete |
H51-24C501C09C128D4AB6E1D2AD | catalog.json/records/160/version_added | Historical; current review incomplete |
H51-DAEF482F8D4C6847B5F5862E | catalog.json/records/160/sources/0 | Historical; current review incomplete |
H51-E3AAB0CE5C476E5F574DD87F | catalog.json/records/160/sources/0/label | Historical; current review incomplete |
H51-EB504422FD2755A025446D42 | catalog.json/records/160/sources/0/url | Historical; current review incomplete |
H51-171D834AC14770043EB37AAB | catalog.json/records/160/sources/0/kind | Historical; current review incomplete |
H51-B2F6DDFFCD22D4DA43176868 | catalog.json/records/160/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-C007B0AB097874510A8A7CC4 | catalog.json/records/160/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-F6C2D67E49BED6E4911E838A | catalog.json/records/160/clinical_release_verification/level | Historical; current review incomplete |
H51-4060468BAB1C018727A6390E | catalog.json/records/160/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-9EAA1C335F837660E02FB2DB | catalog.json/records/160/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-D3664DB475601587C8517B48 | catalog.json/records/160/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-8E690F79C395E09D7D08100B | catalog.json/records/160/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-1F629C25BD2655097A720DF7 | catalog.json/records/160/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-BB334A644473D6770ECD2FA4 | catalog.json/records/160/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-DB95575473D5546945BAAD88 | catalog.json/records/160/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-D328473C06879295E0C12250 | catalog.json/records/160/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-8BB5484FCDCFB2E7495FC47B | catalog.json/records/160/clinical_release_verification/note | Historical; current review incomplete |
H51-78E0AC608D1C7D0B7FB6B62B | catalog.json/records/160/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-543289438791B36F102ECBEA | dosing.json/records/160/id | Historical; current review incomplete |
H51-5A18A8C76967D5E40E075F71 | dosing.json/records/160/generic_name | Historical; current review incomplete |
H51-34454677382FF9A75C304B67 | dosing.json/records/160/coverage_status | Historical; current review incomplete |
H51-703DDA726FBE68B2346231C6 | dosing.json/records/160/package_insert/query_name | Historical; current review incomplete |
H51-1EC04F47AF06075C50E83377 | dosing.json/records/160/package_insert/preferred_setid | Historical; current review incomplete |
H51-EBE0EB8DD744AF5B5A63D461 | dosing.json/records/160/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-03970CA24BCF41F5A708D066 | dosing.json/records/160/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-DCA0A2B7EECAAB2FAC2A21CB | dosing.json/records/160/package_insert/source_priority | Historical; current review incomplete |
H51-3CA6F5085663BD5C9203AF4D | dosing.json/records/160/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-DE479C093E695A2611DC06F4 | dosing.json/records/160/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-1C03F5BFD67AB63514C0061A | dosing.json/records/160/package_insert/local_summary_status | Historical; current review incomplete |
H51-F4168BC3532B8E3E3EAFDD43 | dosing.json/records/160/renal/classification | Historical; current review incomplete |
H51-C98A71D2389B909ECC077380 | dosing.json/records/160/renal/summary | Historical; current review incomplete |
H51-9B5AE7176954A860E71D34D9 | dosing.json/records/160/renal/method_note | Historical; current review incomplete |
H51-7290D477CF255535460B4347 | dosing.json/records/160/clinical_review/locally_normalized | Historical; current review incomplete |
H51-D85F64926E5E7C2B9BDBE3D9 | dosing.json/records/160/clinical_review/reviewed | Historical; current review incomplete |
H51-F8AF1C300ACAC19F022AB65C | dosing.json/records/160/clinical_review/status | Historical; current review incomplete |
H51-ADF4F681A47FA10558369B71 | dosing.json/records/160/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-A8CF1397C282100F37DD3668 | dosing.json/records/160/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-8409C143A735FC3231DAD322 | dosing.json/records/160/clinical_release_verification/level | Historical; current review incomplete |
H51-73C8655EEBC92749F2BA25CD | dosing.json/records/160/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-3A15AA86C23195BD45F1E928 | dosing.json/records/160/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-4D171A28605399DFDA7F0931 | dosing.json/records/160/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-7559D77038917517B2DA4744 | dosing.json/records/160/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-6AD0C614DEC3E723C643CE27 | dosing.json/records/160/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-D75502812A6C286DF2F12BC8 | dosing.json/records/160/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-05A2E176391FCB175039ED97 | dosing.json/records/160/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-0AE8E7373E09B024576961BF | dosing.json/records/160/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-EF6374528D69AF4C91A13405 | dosing.json/records/160/clinical_release_verification/note | Historical; current review incomplete |
H51-937A6EC4F8241AEE5072C42B | dosing.json/records/160/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-730F468E90E964C21FBE80CD | first-look-v5.1.json/records/160/id | Historical; current review incomplete |
H51-F1D88445CB888C7A6C966AA8 | first-look-v5.1.json/records/160/generic_name | Historical; current review incomplete |
H51-A11884D959C266D932EB856F | first-look-v5.1.json/records/160/class | Historical; current review incomplete |
H51-0537D4929FDDD20630146814 | first-look-v5.1.json/records/160/subclass | Historical; current review incomplete |
H51-5522CEDA1923435F2A322EA1 | first-look-v5.1.json/records/160/primary_uses/0 | Historical; current review incomplete |
H51-43759731FCA61E21C98898FF | first-look-v5.1.json/records/160/mechanism | Historical; current review incomplete |
H51-9290CF203F8D5B00629AF64E | first-look-v5.1.json/records/160/mechanism_level | Historical; current review incomplete |
H51-0F8475E8DF76904A137E6CF2 | first-look-v5.1.json/records/160/basic_dosing_orientation | Historical; current review incomplete |
H51-77A964941A048BA4883392FE | first-look-v5.1.json/records/160/administration_orientation | Historical; current review incomplete |
H51-6873FC4EC122748ACCAA7164 | first-look-v5.1.json/records/160/renal_and_population_orientation | Historical; current review incomplete |
H51-EC9BD8CFFF09053B082BC221 | first-look-v5.1.json/records/160/key_safety_orientation/0 | Historical; current review incomplete |
H51-EB32D431FD22C7E7B7C5279B | first-look-v5.1.json/records/160/coverage_path | Historical; current review incomplete |
H51-61949560B20F933B302DBD26 | first-look-v5.1.json/records/160/coverage_path_label | Historical; current review incomplete |
H51-DF5C059995E2053FFCC165D7 | first-look-v5.1.json/records/160/official_label_url | Historical; current review incomplete |
H51-20582276493F697FC43D2C4D | first-look-v5.1.json/records/160/legacy_title | Historical; current review incomplete |
H51-1859732C4F53737ADABD0530 | first-look-v5.1.json/records/160/review_note | Historical; current review incomplete |
H51-B7D4902223E585E16074C63B | first-look-v5.1.json/records/160/search_text | Historical; current review incomplete |
H51-FC01089F8E5F731D3FE61B93 | first-look-v5.1.json/records/160/official_search_url | Historical; current review incomplete |
H51-FB6AD8EEBBE830B361F27121 | first-look-v5.1.json/records/160/official_access_mode | Historical; current review incomplete |
H51-8964F59F84BE7D3DEB8AE4DD | first-look-v5.1.json/records/160/official_access_url | Historical; current review incomplete |
H51-93EB10025A6B63D5C30FEF38 | first-look-v5.1.json/records/160/official_search_query | Historical; current review incomplete |
H51-F91C1BED0249209EDE09E85A | first-look-v5.1.json/records/160/official_access_reason | Historical; current review incomplete |
H51-3D3F3D57EA9900A668EB1244 | preparation-assessments-v3.8.json/160/id | Historical; current review incomplete |
H51-AAAB03FDFB296CC66447690E | preparation-assessments-v3.8.json/160/name | Historical; current review incomplete |
H51-663AFB35F0DF754399DEEBDC | preparation-assessments-v3.8.json/160/brands | Historical; current review incomplete |
H51-DB6CC7C3B0468AD37296DF97 | preparation-assessments-v3.8.json/160/therapeutic_class | Historical; current review incomplete |
H51-B7ECFF0E7EAF5E77726FB400 | preparation-assessments-v3.8.json/160/review_version | Historical; current review incomplete |
H51-59F6F25E9304E9614727A963 | preparation-assessments-v3.8.json/160/review_date | Historical; current review incomplete |
H51-9B2F44A8D37345181B940FC0 | preparation-assessments-v3.8.json/160/release_status | Historical; current review incomplete |
H51-DD106E013185F790A6C2D0A7 | preparation-assessments-v3.8.json/160/market_status/status | Historical; current review incomplete |
H51-6BA0DDC9912045C65963D8EF | preparation-assessments-v3.8.json/160/market_status/basis | Historical; current review incomplete |
H51-A1A5B7E01A995A7D945FE279 | preparation-assessments-v3.8.json/160/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-6611F6E69FF5EEB866816E7F | preparation-assessments-v3.8.json/160/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-9FD2AD903232D089ACD76502 | preparation-assessments-v3.8.json/160/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-12D3DCEC8C8B88D4705C4F45 | preparation-assessments-v3.8.json/160/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-FCE4DC838007CD8DC05DAED5 | preparation-assessments-v3.8.json/160/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-7AC122FA7C59B5E4155663D6 | preparation-assessments-v3.8.json/160/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-08A619A5484766D799AB0020 | preparation-assessments-v3.8.json/160/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-1CBB45269A2F7E228AB6168D | preparation-assessments-v3.8.json/160/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-A00AE9D19A7178CEE0E382F2 | preparation-assessments-v3.8.json/160/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-441F98AAB07F0F1754A43051 | preparation-assessments-v3.8.json/160/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-A3372B3303ED12C4BA02CB33 | preparation-assessments-v3.8.json/160/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-7EB5D85CA425A7BA5C05C638 | preparation-assessments-v3.8.json/160/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-5726D97D982C5D2910230997 | preparation-assessments-v3.8.json/160/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-1F2C377A5D902D4F6651D9BF | preparation-assessments-v3.8.json/160/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-977187AD31BFCD468327A37D | preparation-assessments-v3.8.json/160/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-9983A0534CA980610CE46A78 | preparation-assessments-v3.8.json/160/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-296B733E8DF7540FF7F2E175 | preparation-assessments-v3.8.json/160/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-9386C8CCEF524C4CD4F1A047 | preparation-assessments-v3.8.json/160/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-317EF84A314F497B650D0A16 | preparation-assessments-v3.8.json/160/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-BC7FDE570FAA4F13FAF7069C | preparation-assessments-v3.8.json/160/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-95D08E09B3229D0C1C5FBB75 | preparation-assessments-v3.8.json/160/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-526AD33A1A990DB1418FEDB3 | preparation-assessments-v3.8.json/160/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-37EF8E84ACB92A6B5AA362D9 | preparation-assessments-v3.8.json/160/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-712C6A39E0D56CE981DBA095 | preparation-assessments-v3.8.json/160/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-35501767652A2B7CE7F61327 | preparation-assessments-v3.8.json/160/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-D373A3D3EB7CCFF7BB25252C | preparation-assessments-v3.8.json/160/population_applicability/adult/applicability | Historical; current review incomplete |
H51-6893226C8E096EB48BC44D42 | preparation-assessments-v3.8.json/160/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-EF57071A832D483E11716B58 | preparation-assessments-v3.8.json/160/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-3AC695377E9F04E088426CC4 | preparation-assessments-v3.8.json/160/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-BE46CED045EF5ADE4C6F98B2 | preparation-assessments-v3.8.json/160/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-DB99074F7314DDCA208C4251 | preparation-assessments-v3.8.json/160/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-EF91EBD5061CF02CF3230752 | preparation-assessments-v3.8.json/160/route_presence/structured_dilution | Historical; current review incomplete |
H51-90C2997E64718AE4DB8E0B15 | preparation-assessments-v3.8.json/160/route_presence/iv_push | Historical; current review incomplete |
H51-DD331FAFE003374CFC5EBF93 | preparation-assessments-v3.8.json/160/route_presence/continuous_infusion | Historical; current review incomplete |
H51-4C00E1F6989F165690F44800 | preparation-assessments-v3.8.json/160/route_presence/pediatric_source | Historical; current review incomplete |
H51-36F8F0C489D6E7201F856EDC | preparation-assessments-v3.8.json/160/route_presence/neonatal_source | Historical; current review incomplete |
H51-98059E41404ADFF8F65A549D | preparation-assessments-v3.8.json/160/legacy_reference/status | Historical; current review incomplete |
H51-8CA9FBE9EC35E59F12336D8D | preparation-assessments-v3.8.json/160/label_resolution/status | Historical; current review incomplete |
H51-F32F27884D1F7FD44668CE81 | preparation-assessments-v3.8.json/160/source_files/0 | Historical; current review incomplete |
H51-890B22A1D71355AEB519EA65 | preparation-assessments-v3.8.json/160/source_files/1 | Historical; current review incomplete |
H51-93E483296E03D93AF04ED495 | preparation-assessments-v3.8.json/160/source_files/2 | Historical; current review incomplete |
H51-A5A309E82665D119A2054A00 | preparation-assessments-v3.8.json/160/source_files/3 | Historical; current review incomplete |
H51-95E34F78E16C2930CF334886 | preparation-assessments-v3.8.json/160/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)